Glenn Coleman insider trades
Open-market stock purchases and sales by Glenn Coleman, EVP & Chief Financial Officer at Charles River Laboratories International, Inc, from SEC Form 4 filings since Jan 12, 2010.
Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging -27%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 30, 2026 | CRL Charles River Laboratories International, Inc | Bought | $3K |
| May 29, 2026 | CRL Charles River Laboratories International, Inc | Bought (not open market) | $1.2M |
| May 1, 2026 | CRL Charles River Laboratories International, Inc | Bought (not open market) | $3.5M |
| Nov 25, 2025 | PINC Premier, Inc | Sold (not open market) | $4.6M |
| Nov 25, 2025 | PINC Premier, Inc | Sold (not open market) | — |
| Nov 11, 2025 | PINC Premier, Inc | Sold (not open market) | $109K |
| Nov 11, 2025 | PINC Premier, Inc | Sold (not open market) | $480K |